| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Kinase C | 82 | 2017 | 1205 | 7.810 |
Why?
|
| Diabetic Angiopathies | 36 | 2024 | 805 | 5.330 |
Why?
|
| Diabetic Nephropathies | 28 | 2022 | 968 | 4.930 |
Why?
|
| Diabetes Mellitus, Experimental | 41 | 2022 | 1119 | 4.170 |
Why?
|
| Insulin Resistance | 41 | 2024 | 3988 | 3.910 |
Why?
|
| Diabetic Retinopathy | 33 | 2025 | 1294 | 3.800 |
Why?
|
| Diabetes Mellitus, Type 1 | 36 | 2025 | 3445 | 3.410 |
Why?
|
| Insulin | 65 | 2024 | 6603 | 2.860 |
Why?
|
| Muscle, Smooth, Vascular | 29 | 2024 | 1494 | 2.540 |
Why?
|
| Endothelium, Vascular | 51 | 2021 | 4423 | 2.520 |
Why?
|
| Receptor, Insulin | 34 | 2024 | 838 | 2.480 |
Why?
|
| Retinal Vessels | 30 | 2021 | 848 | 2.400 |
Why?
|
| Protein Kinase C-delta | 10 | 2017 | 115 | 2.140 |
Why?
|
| Diglycerides | 27 | 2010 | 175 | 1.970 |
Why?
|
| Insulin Receptor Substrate Proteins | 13 | 2021 | 558 | 1.960 |
Why?
|
| Diabetes Mellitus | 26 | 2024 | 5882 | 1.910 |
Why?
|
| Glucose | 32 | 2019 | 4335 | 1.820 |
Why?
|
| Hyperglycemia | 32 | 2023 | 1389 | 1.790 |
Why?
|
| Pyruvate Kinase | 3 | 2022 | 192 | 1.740 |
Why?
|
| Retina | 31 | 2024 | 2646 | 1.670 |
Why?
|
| Isoenzymes | 33 | 2017 | 1688 | 1.650 |
Why?
|
| Atherosclerosis | 13 | 2024 | 3417 | 1.630 |
Why?
|
| Kidney Glomerulus | 14 | 2019 | 567 | 1.590 |
Why?
|
| Vascular Endothelial Growth Factor A | 35 | 2022 | 3499 | 1.510 |
Why?
|
| Diabetes Mellitus, Type 2 | 26 | 2025 | 12235 | 1.360 |
Why?
|
| Podocytes | 4 | 2022 | 389 | 1.350 |
Why?
|
| Endothelial Growth Factors | 19 | 2003 | 671 | 1.320 |
Why?
|
| Endothelial Cells | 17 | 2023 | 3586 | 1.280 |
Why?
|
| Lymphokines | 18 | 2003 | 905 | 1.270 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 3 | 2016 | 121 | 1.260 |
Why?
|
| Myocytes, Smooth Muscle | 4 | 2024 | 701 | 1.240 |
Why?
|
| Enzyme Activation | 36 | 2017 | 3584 | 1.240 |
Why?
|
| Rats, Zucker | 15 | 2017 | 129 | 1.210 |
Why?
|
| Periodontitis | 3 | 2023 | 576 | 1.190 |
Why?
|
| Vitreous Body | 5 | 2024 | 399 | 1.160 |
Why?
|
| Receptor, IGF Type 1 | 5 | 2024 | 385 | 1.150 |
Why?
|
| Diabetes Complications | 13 | 2015 | 1317 | 1.120 |
Why?
|
| Retinol-Binding Proteins | 3 | 2024 | 67 | 1.080 |
Why?
|
| Vitamin E | 12 | 2005 | 872 | 1.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 16 | 2024 | 2454 | 1.030 |
Why?
|
| Endothelin-1 | 8 | 2013 | 295 | 1.020 |
Why?
|
| Maleimides | 17 | 2011 | 112 | 1.010 |
Why?
|
| Diabetic Cardiomyopathies | 2 | 2017 | 85 | 0.990 |
Why?
|
| Cattle | 47 | 2013 | 3801 | 0.980 |
Why?
|
| Signal Transduction | 40 | 2024 | 23600 | 0.980 |
Why?
|
| Hyperplasia | 3 | 2019 | 1142 | 0.960 |
Why?
|
| Oxidative Stress | 14 | 2014 | 3140 | 0.930 |
Why?
|
| Rats | 74 | 2017 | 23718 | 0.920 |
Why?
|
| Animals | 177 | 2024 | 168801 | 0.900 |
Why?
|
| Myocardium | 13 | 2017 | 4765 | 0.900 |
Why?
|
| Aqueous Humor | 1 | 2024 | 152 | 0.870 |
Why?
|
| Diabetic Neuropathies | 5 | 2013 | 409 | 0.870 |
Why?
|
| Apolipoproteins E | 6 | 2024 | 1459 | 0.860 |
Why?
|
| Eye Proteins | 4 | 2022 | 628 | 0.840 |
Why?
|
| Angiotensin II | 5 | 2013 | 844 | 0.820 |
Why?
|
| Phosphatidylinositol 3-Kinases | 15 | 2023 | 2878 | 0.810 |
Why?
|
| Cells, Cultured | 67 | 2024 | 18965 | 0.800 |
Why?
|
| Nitric Oxide Synthase Type III | 10 | 2017 | 707 | 0.750 |
Why?
|
| Enzyme Inhibitors | 27 | 2012 | 3722 | 0.740 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2024 | 3801 | 0.730 |
Why?
|
| Retinal Neurons | 1 | 2021 | 66 | 0.710 |
Why?
|
| Macular Edema | 1 | 2025 | 384 | 0.710 |
Why?
|
| Apoptosis | 7 | 2024 | 9507 | 0.700 |
Why?
|
| Endothelium | 14 | 2022 | 768 | 0.680 |
Why?
|
| Mice, Inbred C57BL | 15 | 2024 | 22339 | 0.640 |
Why?
|
| Insulin-Secreting Cells | 4 | 2019 | 899 | 0.630 |
Why?
|
| Aorta | 22 | 2024 | 2040 | 0.630 |
Why?
|
| Rats, Sprague-Dawley | 35 | 2017 | 8114 | 0.620 |
Why?
|
| Aortic Diseases | 1 | 2024 | 741 | 0.620 |
Why?
|
| Somatomedins | 12 | 1990 | 178 | 0.610 |
Why?
|
| Capillaries | 17 | 2021 | 750 | 0.610 |
Why?
|
| Inflammation Mediators | 3 | 2024 | 1890 | 0.600 |
Why?
|
| Mice | 55 | 2024 | 81838 | 0.590 |
Why?
|
| Indoles | 17 | 2011 | 1833 | 0.580 |
Why?
|
| Enzymes | 1 | 2019 | 253 | 0.570 |
Why?
|
| Hyperlipidemias | 2 | 2017 | 770 | 0.570 |
Why?
|
| Kidney | 9 | 2019 | 7072 | 0.560 |
Why?
|
| Cytokines | 6 | 2022 | 7426 | 0.550 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 7 | 2005 | 1656 | 0.550 |
Why?
|
| Hyperinsulinism | 4 | 2016 | 402 | 0.540 |
Why?
|
| Tetradecanoylphorbol Acetate | 9 | 2013 | 822 | 0.530 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2017 | 109 | 0.530 |
Why?
|
| Pericytes | 4 | 2009 | 299 | 0.520 |
Why?
|
| Adipose Tissue, Brown | 1 | 2022 | 775 | 0.520 |
Why?
|
| Antimicrobial Cationic Peptides | 3 | 2007 | 349 | 0.520 |
Why?
|
| Blood Proteins | 3 | 2007 | 1186 | 0.510 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2017 | 292 | 0.510 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2017 | 216 | 0.510 |
Why?
|
| Gene Expression Regulation, Enzymologic | 5 | 2009 | 1167 | 0.510 |
Why?
|
| Immediate-Early Proteins | 3 | 2005 | 444 | 0.510 |
Why?
|
| Growth Substances | 8 | 2002 | 758 | 0.510 |
Why?
|
| Insulin-Like Growth Factor I | 10 | 2019 | 1935 | 0.500 |
Why?
|
| Plaque, Atherosclerotic | 2 | 2024 | 1529 | 0.490 |
Why?
|
| Hypoglycemic Agents | 5 | 2017 | 3106 | 0.470 |
Why?
|
| Receptors, Growth Factor | 6 | 2002 | 324 | 0.470 |
Why?
|
| Tunica Intima | 1 | 2016 | 455 | 0.460 |
Why?
|
| Vascular Endothelial Growth Factors | 18 | 2003 | 748 | 0.460 |
Why?
|
| Receptors, Glucagon | 2 | 2012 | 90 | 0.460 |
Why?
|
| Disease Models, Animal | 9 | 2024 | 18321 | 0.460 |
Why?
|
| Macrophages | 4 | 2017 | 5775 | 0.460 |
Why?
|
| HLA-DQ Antigens | 2 | 2011 | 190 | 0.460 |
Why?
|
| Capillary Permeability | 7 | 2007 | 770 | 0.460 |
Why?
|
| Protein Kinase C-alpha | 4 | 2014 | 112 | 0.450 |
Why?
|
| Phosphorylation | 24 | 2017 | 8290 | 0.450 |
Why?
|
| Macrophage Activation | 1 | 2017 | 553 | 0.450 |
Why?
|
| Vasculitis | 2 | 2014 | 528 | 0.440 |
Why?
|
| RNA, Messenger | 29 | 2012 | 12772 | 0.440 |
Why?
|
| Carbohydrate Metabolism | 1 | 2014 | 261 | 0.430 |
Why?
|
| Mice, Transgenic | 14 | 2019 | 9540 | 0.430 |
Why?
|
| Protein Kinase C-epsilon | 3 | 2014 | 43 | 0.430 |
Why?
|
| Gingivitis | 1 | 2014 | 125 | 0.430 |
Why?
|
| Endothelins | 7 | 1996 | 127 | 0.420 |
Why?
|
| HLA-DR Antigens | 2 | 2011 | 608 | 0.420 |
Why?
|
| Cardiovascular Diseases | 15 | 2018 | 15639 | 0.410 |
Why?
|
| Male | 98 | 2025 | 363880 | 0.410 |
Why?
|
| Cell Proliferation | 4 | 2024 | 10431 | 0.410 |
Why?
|
| Blood Glucose | 16 | 2017 | 6420 | 0.410 |
Why?
|
| Platelet-Derived Growth Factor | 5 | 2012 | 614 | 0.410 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2017 | 1804 | 0.410 |
Why?
|
| Neovascularization, Pathologic | 10 | 2008 | 2627 | 0.400 |
Why?
|
| Pigment Epithelium of Eye | 3 | 2007 | 209 | 0.390 |
Why?
|
| Antioxidants | 9 | 2013 | 1671 | 0.390 |
Why?
|
| Humans | 140 | 2025 | 766019 | 0.390 |
Why?
|
| Diabetic Foot | 1 | 2016 | 383 | 0.380 |
Why?
|
| Gene Expression Regulation | 16 | 2015 | 11906 | 0.380 |
Why?
|
| NF-kappa B | 8 | 2017 | 2495 | 0.380 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2011 | 76 | 0.370 |
Why?
|
| Mice, Knockout | 17 | 2017 | 14457 | 0.370 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2014 | 488 | 0.370 |
Why?
|
| Obesity | 11 | 2022 | 13082 | 0.360 |
Why?
|
| Awards and Prizes | 2 | 2016 | 365 | 0.350 |
Why?
|
| Dietary Carbohydrates | 2 | 2014 | 896 | 0.350 |
Why?
|
| C-Peptide | 3 | 2019 | 443 | 0.350 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2012 | 373 | 0.330 |
Why?
|
| Diacylglycerol Kinase | 5 | 1999 | 47 | 0.310 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 5 | 2015 | 694 | 0.310 |
Why?
|
| Blood Vessels | 4 | 2008 | 1113 | 0.310 |
Why?
|
| Mesangial Cells | 1 | 2008 | 22 | 0.310 |
Why?
|
| Wound Healing | 2 | 2016 | 2795 | 0.300 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 6 | 2002 | 1621 | 0.300 |
Why?
|
| Deoxyglucose | 4 | 2019 | 322 | 0.290 |
Why?
|
| Glypicans | 1 | 2007 | 33 | 0.290 |
Why?
|
| STAT5 Transcription Factor | 1 | 2008 | 268 | 0.290 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2008 | 178 | 0.290 |
Why?
|
| Dyslipidemias | 2 | 2012 | 871 | 0.280 |
Why?
|
| Receptors, Cell Surface | 11 | 1991 | 2815 | 0.280 |
Why?
|
| Heme Oxygenase-1 | 2 | 2012 | 364 | 0.280 |
Why?
|
| Mitochondria | 2 | 2019 | 3676 | 0.280 |
Why?
|
| Cognition | 3 | 2021 | 7050 | 0.280 |
Why?
|
| Angiotensins | 2 | 2007 | 139 | 0.280 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 3 | 2019 | 547 | 0.270 |
Why?
|
| Lipids | 1 | 2017 | 3317 | 0.270 |
Why?
|
| N-Acetylglucosaminyltransferases | 2 | 1999 | 168 | 0.270 |
Why?
|
| Glucose Clamp Technique | 3 | 2019 | 262 | 0.270 |
Why?
|
| Glycolysis | 4 | 2019 | 837 | 0.270 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 3 | 1999 | 279 | 0.270 |
Why?
|
| Fibroblasts | 5 | 2016 | 4161 | 0.260 |
Why?
|
| Inflammation | 6 | 2022 | 10858 | 0.260 |
Why?
|
| Stress, Physiological | 1 | 2012 | 1404 | 0.240 |
Why?
|
| Peptides | 12 | 2012 | 4338 | 0.240 |
Why?
|
| Glomerular Filtration Rate | 5 | 2019 | 2232 | 0.240 |
Why?
|
| Membrane Proteins | 4 | 2007 | 7850 | 0.230 |
Why?
|
| Aged | 27 | 2025 | 171170 | 0.230 |
Why?
|
| Middle Aged | 33 | 2025 | 223035 | 0.230 |
Why?
|
| Up-Regulation | 1 | 2013 | 4133 | 0.230 |
Why?
|
| Rupture, Spontaneous | 1 | 2024 | 360 | 0.220 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 4 | 1997 | 479 | 0.220 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2012 | 4565 | 0.220 |
Why?
|
| Arteriosclerosis | 3 | 2005 | 1055 | 0.220 |
Why?
|
| Cell Movement | 5 | 2019 | 5194 | 0.210 |
Why?
|
| Chemokine CXCL1 | 1 | 2023 | 102 | 0.210 |
Why?
|
| PPAR gamma | 1 | 2006 | 484 | 0.210 |
Why?
|
| Thrombospondin 1 | 1 | 2024 | 256 | 0.210 |
Why?
|
| Time Factors | 17 | 2024 | 40100 | 0.210 |
Why?
|
| Thiazolidinediones | 1 | 2006 | 460 | 0.210 |
Why?
|
| Insulin-Like Growth Factor II | 7 | 1991 | 271 | 0.210 |
Why?
|
| Drug Implants | 2 | 2017 | 230 | 0.210 |
Why?
|
| Female | 44 | 2025 | 396174 | 0.210 |
Why?
|
| Cross-Sectional Studies | 10 | 2021 | 26280 | 0.200 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 5 | 2012 | 693 | 0.200 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2017 | 2469 | 0.200 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2024 | 462 | 0.200 |
Why?
|
| Rats, Inbred Lew | 2 | 2019 | 1168 | 0.200 |
Why?
|
| Kidney Cortex | 4 | 2009 | 167 | 0.200 |
Why?
|
| Communication Barriers | 1 | 2006 | 418 | 0.200 |
Why?
|
| Cardiomegaly | 2 | 2009 | 590 | 0.200 |
Why?
|
| Microcirculation | 10 | 2003 | 1282 | 0.200 |
Why?
|
| Blood Circulation | 3 | 2005 | 248 | 0.200 |
Why?
|
| Blotting, Western | 6 | 2017 | 5019 | 0.200 |
Why?
|
| Edema | 1 | 2006 | 763 | 0.200 |
Why?
|
| 3-O-Methylglucose | 2 | 2019 | 37 | 0.190 |
Why?
|
| Gene Knockdown Techniques | 2 | 2017 | 1603 | 0.190 |
Why?
|
| Receptors, Endothelin | 4 | 1996 | 56 | 0.190 |
Why?
|
| Aldehyde Reductase | 4 | 2005 | 67 | 0.190 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2021 | 58 | 0.190 |
Why?
|
| Retinal Neovascularization | 2 | 2002 | 286 | 0.180 |
Why?
|
| Cardiomyopathies | 4 | 2002 | 2061 | 0.180 |
Why?
|
| Neovascularization, Physiologic | 2 | 2010 | 1370 | 0.180 |
Why?
|
| Immunoblotting | 3 | 2016 | 1644 | 0.180 |
Why?
|
| Recombinant Proteins | 6 | 2019 | 6492 | 0.180 |
Why?
|
| Glomerular Mesangium | 4 | 2000 | 97 | 0.180 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1999 | 489 | 0.180 |
Why?
|
| Neutrophil Infiltration | 1 | 2023 | 393 | 0.180 |
Why?
|
| Disease Progression | 6 | 2025 | 13614 | 0.180 |
Why?
|
| Kinetics | 15 | 1999 | 6273 | 0.180 |
Why?
|
| Islets of Langerhans Transplantation | 3 | 2008 | 746 | 0.170 |
Why?
|
| Necrosis | 1 | 2024 | 1614 | 0.170 |
Why?
|
| Fibrosis | 4 | 2017 | 2073 | 0.170 |
Why?
|
| Enzyme Activators | 1 | 2000 | 56 | 0.170 |
Why?
|
| Vascular Diseases | 2 | 2000 | 1161 | 0.170 |
Why?
|
| Adipose Tissue | 7 | 2006 | 3314 | 0.170 |
Why?
|
| Case-Control Studies | 8 | 2021 | 22230 | 0.170 |
Why?
|
| C-Reactive Protein | 4 | 2022 | 3853 | 0.170 |
Why?
|
| Streptozocin | 3 | 2017 | 189 | 0.170 |
Why?
|
| Regional Blood Flow | 8 | 2000 | 1479 | 0.170 |
Why?
|
| Gene Expression | 8 | 2021 | 7581 | 0.170 |
Why?
|
| Nitric Oxide Synthase | 4 | 2003 | 911 | 0.170 |
Why?
|
| Extracellular Matrix | 2 | 2024 | 1727 | 0.170 |
Why?
|
| Glycerides | 2 | 1989 | 67 | 0.170 |
Why?
|
| Aryldialkylphosphatase | 1 | 2019 | 64 | 0.160 |
Why?
|
| Tomography, Optical Coherence | 2 | 2024 | 2877 | 0.160 |
Why?
|
| Cell Division | 10 | 2002 | 4467 | 0.160 |
Why?
|
| Glutathione | 2 | 2012 | 589 | 0.160 |
Why?
|
| Protein Kinase Inhibitors | 6 | 2016 | 5695 | 0.160 |
Why?
|
| Dental Plaque Index | 1 | 2019 | 96 | 0.160 |
Why?
|
| Glycosylation | 4 | 2008 | 1099 | 0.160 |
Why?
|
| Periodontal Attachment Loss | 1 | 2019 | 151 | 0.160 |
Why?
|
| HLA-A Antigens | 1 | 2019 | 223 | 0.160 |
Why?
|
| Cell Line | 7 | 2017 | 15545 | 0.160 |
Why?
|
| Acids | 1 | 2019 | 125 | 0.160 |
Why?
|
| Lipopolysaccharides | 2 | 2023 | 2212 | 0.160 |
Why?
|
| Metabolomics | 2 | 2019 | 1674 | 0.150 |
Why?
|
| Nitric Oxide | 2 | 2022 | 2142 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2002 | 1241 | 0.150 |
Why?
|
| Connective Tissue Growth Factor | 3 | 2005 | 91 | 0.150 |
Why?
|
| Phosphoserine | 2 | 1999 | 203 | 0.150 |
Why?
|
| Fluorescein Angiography | 7 | 2000 | 1050 | 0.150 |
Why?
|
| Transfection | 7 | 2017 | 5739 | 0.150 |
Why?
|
| Reactive Oxygen Species | 4 | 2017 | 2144 | 0.150 |
Why?
|
| Protein Isoforms | 2 | 2002 | 1715 | 0.150 |
Why?
|
| Femur | 1 | 2024 | 1309 | 0.150 |
Why?
|
| Serpins | 1 | 2000 | 244 | 0.150 |
Why?
|
| Retinoblastoma Protein | 1 | 2002 | 666 | 0.150 |
Why?
|
| Protective Agents | 1 | 2019 | 151 | 0.150 |
Why?
|
| Phlorhizin | 1 | 2017 | 37 | 0.150 |
Why?
|
| Vasodilation | 3 | 2010 | 969 | 0.150 |
Why?
|
| Periodontal Diseases | 2 | 2014 | 453 | 0.150 |
Why?
|
| RNA Interference | 3 | 2017 | 2825 | 0.140 |
Why?
|
| Models, Biological | 8 | 2015 | 9446 | 0.140 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2019 | 203 | 0.140 |
Why?
|
| Adrenergic beta-2 Receptor Antagonists | 1 | 2017 | 12 | 0.140 |
Why?
|
| Receptors, CXCR4 | 1 | 2022 | 729 | 0.140 |
Why?
|
| Intravitreal Injections | 1 | 2019 | 391 | 0.140 |
Why?
|
| Half-Life | 2 | 2016 | 645 | 0.140 |
Why?
|
| Tyrosine | 4 | 2013 | 1427 | 0.140 |
Why?
|
| Patient Education as Topic | 2 | 2013 | 2332 | 0.140 |
Why?
|
| Heart Diseases | 1 | 2010 | 2817 | 0.140 |
Why?
|
| Metabolic Diseases | 2 | 2015 | 686 | 0.140 |
Why?
|
| Serine | 4 | 2013 | 828 | 0.140 |
Why?
|
| Osteocalcin | 1 | 2017 | 271 | 0.140 |
Why?
|
| Nerve Growth Factors | 1 | 2000 | 564 | 0.140 |
Why?
|
| Receptors, Somatomedin | 10 | 1991 | 57 | 0.140 |
Why?
|
| Retinopathy of Prematurity | 1 | 2002 | 449 | 0.140 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2011 | 615 | 0.140 |
Why?
|
| Diet | 2 | 2014 | 8085 | 0.140 |
Why?
|
| Transforming Growth Factor beta | 4 | 2015 | 1996 | 0.130 |
Why?
|
| Finland | 1 | 2018 | 608 | 0.130 |
Why?
|
| Monosaccharide Transport Proteins | 3 | 1998 | 437 | 0.130 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2006 | 2046 | 0.130 |
Why?
|
| Risk Factors | 13 | 2024 | 74837 | 0.130 |
Why?
|
| Prostaglandins | 1 | 1997 | 396 | 0.130 |
Why?
|
| Cell Hypoxia | 4 | 2016 | 656 | 0.130 |
Why?
|
| Femoral Artery | 2 | 2019 | 826 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2005 | 4520 | 0.130 |
Why?
|
| Heart | 3 | 2009 | 4416 | 0.130 |
Why?
|
| DNA, Complementary | 3 | 1995 | 1984 | 0.130 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 2007 | 1724 | 0.130 |
Why?
|
| Weight Gain | 1 | 2006 | 2356 | 0.130 |
Why?
|
| Myocardial Ischemia | 2 | 2006 | 2130 | 0.130 |
Why?
|
| Flow Cytometry | 3 | 2016 | 5879 | 0.130 |
Why?
|
| Fatty Liver | 2 | 2013 | 810 | 0.130 |
Why?
|
| Angiography | 1 | 2021 | 1589 | 0.130 |
Why?
|
| Blotting, Northern | 9 | 2004 | 1546 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2018 | 640 | 0.120 |
Why?
|
| Base Sequence | 8 | 2012 | 12405 | 0.120 |
Why?
|
| Phosphoproteins | 5 | 2005 | 2445 | 0.120 |
Why?
|
| Plasminogen Activator Inhibitor 2 | 1 | 1995 | 19 | 0.120 |
Why?
|
| Transcription, Genetic | 8 | 2004 | 7599 | 0.120 |
Why?
|
| Autopsy | 1 | 2019 | 1011 | 0.120 |
Why?
|
| Cell Membrane | 8 | 2007 | 3635 | 0.120 |
Why?
|
| Cholesterol, HDL | 2 | 2019 | 1811 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 14 | 2004 | 10737 | 0.120 |
Why?
|
| Reference Values | 4 | 2007 | 4909 | 0.120 |
Why?
|
| Kidney Failure, Chronic | 2 | 2021 | 2504 | 0.120 |
Why?
|
| Phospholipases A | 1 | 1995 | 204 | 0.120 |
Why?
|
| Homozygote | 1 | 2019 | 1774 | 0.120 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 799 | 0.120 |
Why?
|
| Transcription Factor RelA | 2 | 2014 | 252 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-sis | 2 | 2007 | 254 | 0.120 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 6 | 2002 | 658 | 0.120 |
Why?
|
| Arginine | 2 | 2024 | 931 | 0.120 |
Why?
|
| Triglycerides | 3 | 2018 | 2441 | 0.110 |
Why?
|
| Proteomics | 2 | 2019 | 3907 | 0.110 |
Why?
|
| Oncogene Protein v-akt | 1 | 2014 | 130 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 1490 | 0.110 |
Why?
|
| RNA, Small Interfering | 4 | 2012 | 3423 | 0.110 |
Why?
|
| Hemoglobins | 1 | 2000 | 1531 | 0.110 |
Why?
|
| Creatinine | 1 | 1999 | 1916 | 0.110 |
Why?
|
| Lysine | 2 | 2024 | 994 | 0.110 |
Why?
|
| Myocytes, Cardiac | 3 | 2009 | 1674 | 0.110 |
Why?
|
| Galactosemias | 1 | 1994 | 124 | 0.110 |
Why?
|
| Eye | 1 | 1997 | 710 | 0.110 |
Why?
|
| Interleukin-18 | 1 | 2015 | 251 | 0.110 |
Why?
|
| Sodium-Glucose Transport Proteins | 1 | 2013 | 13 | 0.110 |
Why?
|
| Salix | 1 | 2012 | 3 | 0.110 |
Why?
|
| Methylglucosides | 1 | 1993 | 35 | 0.110 |
Why?
|
| Cytosol | 5 | 1995 | 885 | 0.110 |
Why?
|
| Health | 2 | 2015 | 397 | 0.110 |
Why?
|
| Hemodynamics | 7 | 2003 | 4188 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2023 | 4342 | 0.100 |
Why?
|
| Regeneration | 1 | 2022 | 1516 | 0.100 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1997 | 833 | 0.100 |
Why?
|
| Lipoproteins, HDL | 1 | 2017 | 676 | 0.100 |
Why?
|
| Malondialdehyde | 1 | 2012 | 113 | 0.100 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 1992 | 110 | 0.100 |
Why?
|
| Biological Transport | 6 | 2003 | 2080 | 0.100 |
Why?
|
| Type C Phospholipases | 2 | 2007 | 284 | 0.100 |
Why?
|
| Threonine | 1 | 2013 | 272 | 0.100 |
Why?
|
| Deoxyguanosine | 1 | 2012 | 96 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2007 | 472 | 0.100 |
Why?
|
| Autoantibodies | 3 | 2019 | 2114 | 0.100 |
Why?
|
| Cohort Studies | 5 | 2021 | 41677 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2007 | 477 | 0.100 |
Why?
|
| Venoms | 1 | 2012 | 94 | 0.100 |
Why?
|
| Albuminuria | 5 | 2005 | 659 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2012 | 205 | 0.100 |
Why?
|
| Arterioles | 1 | 1992 | 251 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2011 | 414 | 0.100 |
Why?
|
| Diet, Fat-Restricted | 1 | 2014 | 328 | 0.100 |
Why?
|
| Gangliosides | 2 | 1992 | 132 | 0.090 |
Why?
|
| Phorbol Esters | 1 | 1991 | 108 | 0.090 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2018 | 1362 | 0.090 |
Why?
|
| Tissue Culture Techniques | 1 | 2012 | 286 | 0.090 |
Why?
|
| Epithelium | 3 | 1994 | 1604 | 0.090 |
Why?
|
| Thymidine | 5 | 1993 | 294 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2006 | 4053 | 0.090 |
Why?
|
| Molecular Sequence Data | 9 | 1998 | 17597 | 0.090 |
Why?
|
| Hexosephosphates | 1 | 1990 | 24 | 0.090 |
Why?
|
| Fructose | 1 | 2013 | 284 | 0.090 |
Why?
|
| Mannosephosphates | 1 | 1990 | 11 | 0.090 |
Why?
|
| Numismatics | 1 | 2010 | 16 | 0.090 |
Why?
|
| Monocytes | 2 | 2017 | 2591 | 0.090 |
Why?
|
| Alveolar Bone Loss | 1 | 2014 | 394 | 0.090 |
Why?
|
| DNA | 11 | 2002 | 7192 | 0.090 |
Why?
|
| Rats, Inbred Strains | 5 | 1992 | 2077 | 0.090 |
Why?
|
| Cell Cycle Proteins | 1 | 2002 | 3436 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 6 | 2007 | 6057 | 0.090 |
Why?
|
| Dietary Fiber | 1 | 2014 | 767 | 0.090 |
Why?
|
| Blood Flow Velocity | 6 | 2003 | 1378 | 0.090 |
Why?
|
| Flavonoids | 2 | 2006 | 446 | 0.090 |
Why?
|
| Receptors, Angiotensin | 3 | 2001 | 141 | 0.090 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 59497 | 0.080 |
Why?
|
| Blindness | 2 | 2013 | 584 | 0.080 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2012 | 385 | 0.080 |
Why?
|
| Cell Adhesion | 2 | 2010 | 3089 | 0.080 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2013 | 364 | 0.080 |
Why?
|
| Protein C | 1 | 2010 | 134 | 0.080 |
Why?
|
| Maf Transcription Factors, Large | 1 | 2009 | 21 | 0.080 |
Why?
|
| Mice, Nude | 1 | 2016 | 3610 | 0.080 |
Why?
|
| Reperfusion | 1 | 2010 | 268 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 3796 | 0.080 |
Why?
|
| DNA Fragmentation | 1 | 2009 | 238 | 0.080 |
Why?
|
| Plant Extracts | 1 | 2012 | 496 | 0.080 |
Why?
|
| Peptides, Cyclic | 4 | 2000 | 390 | 0.080 |
Why?
|
| B-Lymphocytes | 1 | 2002 | 4783 | 0.080 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2009 | 183 | 0.080 |
Why?
|
| Binding, Competitive | 7 | 1993 | 1140 | 0.080 |
Why?
|
| Body Mass Index | 3 | 2018 | 13042 | 0.080 |
Why?
|
| Peptide Fragments | 5 | 2015 | 5125 | 0.080 |
Why?
|
| Cholesterol | 1 | 2018 | 2901 | 0.080 |
Why?
|
| Amino Acid Sequence | 9 | 1995 | 13400 | 0.080 |
Why?
|
| Cell Cycle | 1 | 2016 | 2921 | 0.080 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2012 | 637 | 0.080 |
Why?
|
| Adenoviridae | 3 | 2003 | 1092 | 0.080 |
Why?
|
| Molecular Weight | 5 | 1993 | 2161 | 0.080 |
Why?
|
| Caspase 8 | 1 | 2008 | 198 | 0.070 |
Why?
|
| Renin-Angiotensin System | 1 | 2013 | 736 | 0.070 |
Why?
|
| Genes, Dominant | 2 | 2008 | 855 | 0.070 |
Why?
|
| Polysaccharide-Lyases | 1 | 2007 | 48 | 0.070 |
Why?
|
| Proto-Oncogenes | 1 | 1989 | 320 | 0.070 |
Why?
|
| Tritium | 3 | 1994 | 702 | 0.070 |
Why?
|
| Rats, Inbred BN | 3 | 1996 | 229 | 0.070 |
Why?
|
| Troponin I | 2 | 2005 | 656 | 0.070 |
Why?
|
| Receptors, Gastrointestinal Hormone | 1 | 2007 | 45 | 0.070 |
Why?
|
| DNA-Binding Proteins | 3 | 2012 | 9600 | 0.070 |
Why?
|
| Oxidants | 2 | 2004 | 167 | 0.070 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2007 | 61 | 0.070 |
Why?
|
| Longitudinal Studies | 4 | 2018 | 14747 | 0.070 |
Why?
|
| Endocytosis | 1 | 1991 | 952 | 0.070 |
Why?
|
| Immunologic Techniques | 2 | 2002 | 212 | 0.070 |
Why?
|
| Phenotype | 3 | 2011 | 16714 | 0.070 |
Why?
|
| Captopril | 1 | 2007 | 261 | 0.070 |
Why?
|
| Islets of Langerhans | 3 | 2007 | 1349 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 1999 | 3426 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 15882 | 0.060 |
Why?
|
| Ubiquitination | 1 | 2011 | 1000 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 3 | 2008 | 5784 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2012 | 997 | 0.060 |
Why?
|
| Receptors, Notch | 1 | 2010 | 751 | 0.060 |
Why?
|
| Adult | 18 | 2021 | 223110 | 0.060 |
Why?
|
| DNA Damage | 1 | 2015 | 2464 | 0.060 |
Why?
|
| Hexosamines | 1 | 2005 | 40 | 0.060 |
Why?
|
| Aorta, Abdominal | 3 | 1999 | 626 | 0.060 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2005 | 55 | 0.060 |
Why?
|
| Proteins | 1 | 2000 | 5994 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 2306 | 0.060 |
Why?
|
| Cyclic GMP | 1 | 2006 | 394 | 0.060 |
Why?
|
| United States | 7 | 2021 | 72918 | 0.060 |
Why?
|
| Epidermal Growth Factor | 1 | 1987 | 697 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 1995 | 1056 | 0.060 |
Why?
|
| RNA | 4 | 2007 | 2715 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2018 | 9351 | 0.060 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 1997 | 433 | 0.060 |
Why?
|
| Bone Matrix | 1 | 2024 | 126 | 0.060 |
Why?
|
| Trypsin | 3 | 1994 | 487 | 0.060 |
Why?
|
| Health Surveys | 1 | 2014 | 4054 | 0.060 |
Why?
|
| Arachidonic Acid | 2 | 1997 | 429 | 0.060 |
Why?
|
| Genotype | 3 | 2018 | 13027 | 0.060 |
Why?
|
| Public Health Practice | 1 | 2006 | 219 | 0.060 |
Why?
|
| Substrate Specificity | 2 | 2000 | 1751 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2014 | 8723 | 0.060 |
Why?
|
| Adenosine | 3 | 1998 | 813 | 0.060 |
Why?
|
| Androstadienes | 1 | 2006 | 347 | 0.060 |
Why?
|
| Cognition Disorders | 1 | 2018 | 3966 | 0.060 |
Why?
|
| Photoreceptor Cells | 1 | 2005 | 234 | 0.060 |
Why?
|
| Cardiovascular Agents | 1 | 2010 | 847 | 0.060 |
Why?
|
| Erythropoietin | 1 | 2008 | 716 | 0.050 |
Why?
|
| Monensin | 3 | 1988 | 30 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2012 | 1475 | 0.050 |
Why?
|
| Leukostasis | 1 | 2003 | 23 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2014 | 5301 | 0.050 |
Why?
|
| Liver | 3 | 2013 | 7558 | 0.050 |
Why?
|
| Boston | 1 | 2016 | 9335 | 0.050 |
Why?
|
| Receptor, Endothelin A | 1 | 2003 | 55 | 0.050 |
Why?
|
| Plasma | 1 | 2006 | 583 | 0.050 |
Why?
|
| Prevalence | 2 | 2018 | 15820 | 0.050 |
Why?
|
| Logistic Models | 1 | 2018 | 13272 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 20135 | 0.050 |
Why?
|
| Patient Compliance | 1 | 2013 | 2694 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2005 | 2879 | 0.050 |
Why?
|
| Thioredoxins | 1 | 2004 | 202 | 0.050 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2024 | 250 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2003 | 812 | 0.050 |
Why?
|
| Muramidase | 1 | 2002 | 163 | 0.050 |
Why?
|
| Adolescent | 8 | 2019 | 88808 | 0.050 |
Why?
|
| Fibronectins | 2 | 1997 | 721 | 0.050 |
Why?
|
| Tissue and Organ Procurement | 1 | 2010 | 988 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 3 | 2000 | 559 | 0.050 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2007 | 1511 | 0.050 |
Why?
|
| Vasa Nervorum | 1 | 2001 | 5 | 0.050 |
Why?
|
| Adiposity | 1 | 2011 | 1892 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2002 | 410 | 0.050 |
Why?
|
| E2F Transcription Factors | 1 | 2002 | 269 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2007 | 1195 | 0.050 |
Why?
|
| Endothelin-3 | 1 | 2000 | 9 | 0.050 |
Why?
|
| Body Weight | 2 | 2014 | 4626 | 0.050 |
Why?
|
| Pregnancy in Diabetics | 1 | 2002 | 198 | 0.040 |
Why?
|
| Dogs | 4 | 1997 | 3825 | 0.040 |
Why?
|
| Arteries | 1 | 1985 | 1121 | 0.040 |
Why?
|
| Collateral Circulation | 1 | 2002 | 289 | 0.040 |
Why?
|
| Cycloheximide | 1 | 2000 | 339 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2002 | 502 | 0.040 |
Why?
|
| Genes, myc | 1 | 2001 | 391 | 0.040 |
Why?
|
| Chemokine CXCL12 | 1 | 2022 | 455 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 634 | 0.040 |
Why?
|
| Thrombin | 1 | 2002 | 600 | 0.040 |
Why?
|
| Lipoproteins | 2 | 2019 | 870 | 0.040 |
Why?
|
| Imidazoles | 2 | 2012 | 1169 | 0.040 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2003 | 462 | 0.040 |
Why?
|
| Ascorbic Acid | 1 | 2003 | 657 | 0.040 |
Why?
|
| Ischemia | 3 | 2010 | 1904 | 0.040 |
Why?
|
| Probucol | 1 | 1999 | 25 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 39233 | 0.040 |
Why?
|
| China | 1 | 2006 | 2383 | 0.040 |
Why?
|
| von Willebrand Factor | 2 | 2000 | 680 | 0.040 |
Why?
|
| PC12 Cells | 1 | 1999 | 316 | 0.040 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1999 | 152 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2015 | 3787 | 0.040 |
Why?
|
| Pertussis Toxin | 1 | 1999 | 174 | 0.040 |
Why?
|
| Receptors, Purinergic P1 | 2 | 1996 | 108 | 0.040 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2002 | 545 | 0.040 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2021 | 386 | 0.040 |
Why?
|
| Immunoglobulins | 1 | 2002 | 853 | 0.040 |
Why?
|
| Saralasin | 2 | 1996 | 34 | 0.040 |
Why?
|
| Metabolic Clearance Rate | 1 | 1999 | 361 | 0.040 |
Why?
|
| Myocardial Contraction | 2 | 2009 | 1516 | 0.040 |
Why?
|
| Phosphotyrosine | 2 | 1996 | 459 | 0.040 |
Why?
|
| Purinergic P1 Receptor Agonists | 1 | 1998 | 39 | 0.040 |
Why?
|
| Receptor, trkA | 1 | 1999 | 159 | 0.040 |
Why?
|
| Administration, Oral | 2 | 1997 | 4016 | 0.040 |
Why?
|
| Glucose Intolerance | 2 | 2014 | 578 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2003 | 1881 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 12803 | 0.040 |
Why?
|
| Glycopeptides | 2 | 1996 | 225 | 0.040 |
Why?
|
| Temperature | 4 | 1990 | 2227 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2002 | 1072 | 0.040 |
Why?
|
| Transcription Factor AP-1 | 1 | 1999 | 321 | 0.040 |
Why?
|
| Metalloendopeptidases | 2 | 1996 | 386 | 0.040 |
Why?
|
| Osmolar Concentration | 1 | 1999 | 655 | 0.040 |
Why?
|
| Heat-Shock Proteins | 1 | 2001 | 791 | 0.040 |
Why?
|
| U937 Cells | 1 | 2017 | 259 | 0.040 |
Why?
|
| Peripheral Nerves | 1 | 2001 | 493 | 0.040 |
Why?
|
| Gene Transfer Techniques | 2 | 2004 | 1206 | 0.030 |
Why?
|
| Brain | 4 | 2009 | 27175 | 0.030 |
Why?
|
| DNA, Antisense | 1 | 1996 | 44 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1999 | 582 | 0.030 |
Why?
|
| Protein Kinases | 2 | 2003 | 1610 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2004 | 1354 | 0.030 |
Why?
|
| Chloroquine | 3 | 1986 | 276 | 0.030 |
Why?
|
| Inositol Phosphates | 1 | 1996 | 174 | 0.030 |
Why?
|
| Renal Circulation | 1 | 1997 | 288 | 0.030 |
Why?
|
| Phospholipase C gamma | 1 | 1996 | 130 | 0.030 |
Why?
|
| Injections | 2 | 2000 | 839 | 0.030 |
Why?
|
| Cross-Over Studies | 2 | 2000 | 2108 | 0.030 |
Why?
|
| Renal Plasma Flow | 1 | 1996 | 27 | 0.030 |
Why?
|
| Phosphopeptides | 2 | 1994 | 240 | 0.030 |
Why?
|
| Retinal Diseases | 2 | 2000 | 702 | 0.030 |
Why?
|
| Protease Inhibitors | 2 | 1996 | 750 | 0.030 |
Why?
|
| Quinazolinones | 1 | 1997 | 219 | 0.030 |
Why?
|
| Ventricular Function, Left | 2 | 2009 | 3926 | 0.030 |
Why?
|
| Blood Pressure | 3 | 2006 | 8529 | 0.030 |
Why?
|
| Trisaccharides | 1 | 1995 | 50 | 0.030 |
Why?
|
| Rubidium | 1 | 1995 | 120 | 0.030 |
Why?
|
| Coronary Circulation | 1 | 2002 | 1601 | 0.030 |
Why?
|
| Blood | 1 | 1998 | 597 | 0.030 |
Why?
|
| Biological Evolution | 1 | 1981 | 1075 | 0.030 |
Why?
|
| Calcium | 2 | 1999 | 5770 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 1995 | 2425 | 0.030 |
Why?
|
| Palmitates | 1 | 1995 | 68 | 0.030 |
Why?
|
| Phospholipases A2 | 1 | 1995 | 197 | 0.030 |
Why?
|
| Biological Transport, Active | 1 | 1995 | 323 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 1992 | 9237 | 0.030 |
Why?
|
| Dietary Fats | 2 | 2014 | 2001 | 0.030 |
Why?
|
| Arachidonic Acids | 1 | 1995 | 294 | 0.030 |
Why?
|
| Procollagen | 1 | 2015 | 189 | 0.030 |
Why?
|
| Palmitic Acids | 1 | 1994 | 52 | 0.030 |
Why?
|
| Plasminogen | 1 | 1995 | 144 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 1999 | 945 | 0.030 |
Why?
|
| CHO Cells | 2 | 1994 | 1373 | 0.030 |
Why?
|
| Cross-Linking Reagents | 2 | 1988 | 687 | 0.030 |
Why?
|
| Young Adult | 3 | 2018 | 59858 | 0.030 |
Why?
|
| Reperfusion Injury | 1 | 2021 | 1043 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2006 | 3093 | 0.030 |
Why?
|
| Dinoprostone | 1 | 1997 | 593 | 0.030 |
Why?
|
| Hyperoxia | 1 | 1996 | 259 | 0.030 |
Why?
|
| Child | 4 | 2019 | 80567 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2018 | 16040 | 0.030 |
Why?
|
| Rats, Inbred BB | 1 | 1993 | 29 | 0.030 |
Why?
|
| Pyridines | 2 | 2012 | 2889 | 0.030 |
Why?
|
| Phorbol 12,13-Dibutyrate | 1 | 1993 | 40 | 0.030 |
Why?
|
| Binding Sites | 1 | 2003 | 6002 | 0.030 |
Why?
|
| Leukocytes | 1 | 2022 | 2030 | 0.030 |
Why?
|
| DNA Probes | 1 | 1995 | 541 | 0.030 |
Why?
|
| Iron-Sulfur Proteins | 1 | 1994 | 84 | 0.030 |
Why?
|
| Gene Targeting | 1 | 1997 | 840 | 0.030 |
Why?
|
| Luciferases | 2 | 2008 | 712 | 0.030 |
Why?
|
| Quality of Life | 2 | 2017 | 13464 | 0.030 |
Why?
|
| Palmitic Acid | 1 | 1994 | 147 | 0.030 |
Why?
|
| Cricetinae | 2 | 1994 | 2413 | 0.030 |
Why?
|
| Microscopy, Electron | 2 | 1987 | 2543 | 0.030 |
Why?
|
| Heart Failure | 3 | 2012 | 11816 | 0.030 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2015 | 393 | 0.030 |
Why?
|
| Oxidation-Reduction | 3 | 2005 | 2223 | 0.030 |
Why?
|
| Fundus Oculi | 1 | 1995 | 543 | 0.030 |
Why?
|
| Plant Bark | 1 | 2012 | 9 | 0.030 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2012 | 24 | 0.030 |
Why?
|
| Blood Platelets | 1 | 1984 | 2464 | 0.030 |
Why?
|
| Galactose | 1 | 1994 | 299 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2005 | 1961 | 0.030 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 1994 | 237 | 0.030 |
Why?
|
| Polysaccharides | 1 | 1999 | 1017 | 0.030 |
Why?
|
| Veins | 1 | 1997 | 769 | 0.030 |
Why?
|
| Aorta, Thoracic | 1 | 1999 | 1109 | 0.030 |
Why?
|
| Benzyl Alcohols | 1 | 2012 | 33 | 0.030 |
Why?
|
| Monosaccharides | 1 | 1993 | 64 | 0.030 |
Why?
|
| Phosphatidylcholines | 1 | 1994 | 403 | 0.030 |
Why?
|
| Piperidines | 2 | 2000 | 1664 | 0.030 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2012 | 99 | 0.030 |
Why?
|
| Species Specificity | 2 | 2011 | 2406 | 0.030 |
Why?
|
| Alleles | 2 | 2018 | 6892 | 0.030 |
Why?
|
| Protein Precursors | 1 | 1996 | 1133 | 0.020 |
Why?
|
| Insulin Infusion Systems | 1 | 1994 | 221 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 9525 | 0.020 |
Why?
|
| DNA Primers | 1 | 1996 | 2823 | 0.020 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 2 | 2001 | 178 | 0.020 |
Why?
|
| Bone Density | 1 | 2024 | 3491 | 0.020 |
Why?
|
| Angiotensin Receptor Antagonists | 2 | 1996 | 1058 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2003 | 512 | 0.020 |
Why?
|
| Dactinomycin | 1 | 1991 | 304 | 0.020 |
Why?
|
| Immunoglobulin Fab Fragments | 3 | 1982 | 443 | 0.020 |
Why?
|
| Genes, Reporter | 2 | 2008 | 1524 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 1995 | 992 | 0.020 |
Why?
|
| Quinazolines | 1 | 1997 | 1366 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 1995 | 1836 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2006 | 3458 | 0.020 |
Why?
|
| Laser Coagulation | 2 | 2004 | 334 | 0.020 |
Why?
|
| COS Cells | 1 | 2013 | 1135 | 0.020 |
Why?
|
| Genes | 1 | 1995 | 1824 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2004 | 4910 | 0.020 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2012 | 361 | 0.020 |
Why?
|
| Receptor, IGF Type 2 | 1 | 1990 | 35 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 1999 | 6208 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2018 | 3623 | 0.020 |
Why?
|
| DNA Replication | 3 | 1989 | 1426 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 2017 | 1478 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2011 | 456 | 0.020 |
Why?
|
| Transcription Factors | 3 | 2012 | 12128 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 1995 | 932 | 0.020 |
Why?
|
| Hydrogen Peroxide | 2 | 2005 | 740 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 368 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2014 | 934 | 0.020 |
Why?
|
| Gluconeogenesis | 1 | 2011 | 182 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2002 | 3831 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 1995 | 4163 | 0.020 |
Why?
|
| Autoantigens | 1 | 1994 | 886 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1994 | 2743 | 0.020 |
Why?
|
| Random Allocation | 1 | 1994 | 2395 | 0.020 |
Why?
|
| Blood Vessel Prosthesis | 1 | 1995 | 956 | 0.020 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 1999 | 1337 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2006 | 10380 | 0.020 |
Why?
|
| Executive Function | 1 | 2018 | 1395 | 0.020 |
Why?
|
| Lipogenesis | 1 | 2011 | 217 | 0.020 |
Why?
|
| Culture | 1 | 2013 | 622 | 0.020 |
Why?
|
| Sorbitol | 1 | 1989 | 61 | 0.020 |
Why?
|
| Collagen | 1 | 1997 | 2618 | 0.020 |
Why?
|
| Dietary Proteins | 1 | 2014 | 960 | 0.020 |
Why?
|
| Solubility | 3 | 1999 | 1077 | 0.020 |
Why?
|
| Ouabain | 1 | 1989 | 246 | 0.020 |
Why?
|
| Sulfonamides | 1 | 1998 | 1980 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2000 | 12426 | 0.020 |
Why?
|
| Reoviridae | 1 | 1989 | 162 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 1995 | 8925 | 0.020 |
Why?
|
| Neuraminidase | 1 | 1989 | 190 | 0.020 |
Why?
|
| Dipeptides | 1 | 2010 | 386 | 0.020 |
Why?
|
| Glycerol | 1 | 1989 | 274 | 0.020 |
Why?
|
| Metformin | 1 | 1996 | 903 | 0.020 |
Why?
|
| Hindlimb | 1 | 2010 | 512 | 0.020 |
Why?
|
| Carbon Radioisotopes | 1 | 1989 | 543 | 0.020 |
Why?
|
| Macromolecular Substances | 3 | 1993 | 1430 | 0.020 |
Why?
|
| Inositol | 1 | 1989 | 215 | 0.020 |
Why?
|
| Glucosides | 1 | 2012 | 532 | 0.020 |
Why?
|
| Cardiovascular System | 1 | 2015 | 838 | 0.020 |
Why?
|
| Autoradiography | 2 | 1985 | 723 | 0.020 |
Why?
|
| Fluoresceins | 1 | 1987 | 235 | 0.020 |
Why?
|
| Survival Rate | 1 | 2021 | 12822 | 0.020 |
Why?
|
| Cell Size | 1 | 2009 | 626 | 0.020 |
Why?
|
| Leupeptins | 1 | 1986 | 112 | 0.020 |
Why?
|
| Video Recording | 1 | 1992 | 977 | 0.020 |
Why?
|
| Drug Resistance | 1 | 1992 | 1592 | 0.020 |
Why?
|
| Antigens | 1 | 1992 | 1437 | 0.020 |
Why?
|
| Energy Intake | 1 | 2014 | 2141 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2021 | 6611 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2005 | 65203 | 0.020 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2012 | 883 | 0.020 |
Why?
|
| Diffusion | 1 | 1987 | 808 | 0.020 |
Why?
|
| Succinimides | 1 | 1985 | 83 | 0.020 |
Why?
|
| Educational Status | 1 | 2013 | 2507 | 0.020 |
Why?
|
| Receptors, Virus | 1 | 1989 | 651 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2009 | 940 | 0.020 |
Why?
|
| Retinal Artery | 1 | 1985 | 109 | 0.020 |
Why?
|
| Fasting | 1 | 2011 | 1607 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 1988 | 1029 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2017 | 10089 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2002 | 10260 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2014 | 2392 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2013 | 2501 | 0.010 |
Why?
|
| Oxygen | 1 | 1996 | 4247 | 0.010 |
Why?
|
| Amino Acids | 1 | 1990 | 1711 | 0.010 |
Why?
|
| Sulfonylurea Compounds | 1 | 1985 | 220 | 0.010 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2015 | 1884 | 0.010 |
Why?
|
| Drug Stability | 1 | 1984 | 289 | 0.010 |
Why?
|
| Cyclic AMP | 2 | 1998 | 1467 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 1984 | 422 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2005 | 505 | 0.010 |
Why?
|
| Thioctic Acid | 1 | 2003 | 28 | 0.010 |
Why?
|
| Cytochalasins | 1 | 1982 | 19 | 0.010 |
Why?
|
| Quality Assurance, Health Care | 2 | 2004 | 2171 | 0.010 |
Why?
|
| Acetophenones | 1 | 2002 | 51 | 0.010 |
Why?
|
| Cytochalasin D | 1 | 1982 | 91 | 0.010 |
Why?
|
| Chromones | 1 | 2002 | 148 | 0.010 |
Why?
|
| Growth Hormone | 1 | 1985 | 567 | 0.010 |
Why?
|
| Benzopyrans | 1 | 2002 | 62 | 0.010 |
Why?
|
| alpha-Tocopherol | 1 | 2003 | 127 | 0.010 |
Why?
|
| Glycogen | 1 | 1983 | 252 | 0.010 |
Why?
|
| Cell Separation | 1 | 1988 | 1718 | 0.010 |
Why?
|
| GATA2 Transcription Factor | 1 | 2002 | 158 | 0.010 |
Why?
|
| Decidua | 1 | 2002 | 80 | 0.010 |
Why?
|
| Pancreatectomy | 1 | 2007 | 825 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2003 | 624 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 3750 | 0.010 |
Why?
|
| Rats, Long-Evans | 1 | 2003 | 380 | 0.010 |
Why?
|
| Ribonucleases | 1 | 2002 | 265 | 0.010 |
Why?
|
| Sarcoma, Experimental | 1 | 1982 | 116 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2014 | 3208 | 0.010 |
Why?
|
| Mice, Inbred ICR | 1 | 2002 | 361 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2018 | 18075 | 0.010 |
Why?
|
| Diffusion of Innovation | 1 | 2006 | 723 | 0.010 |
Why?
|
| Haplotypes | 1 | 2008 | 2726 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2002 | 420 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2002 | 26379 | 0.010 |
Why?
|
| Aspirin | 2 | 2004 | 3135 | 0.010 |
Why?
|
| Life Style | 1 | 2013 | 3926 | 0.010 |
Why?
|
| Insulin Antibodies | 1 | 1981 | 28 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1983 | 1300 | 0.010 |
Why?
|
| Protein Binding | 2 | 2004 | 9302 | 0.010 |
Why?
|
| Sex Factors | 1 | 2015 | 10611 | 0.010 |
Why?
|
| Dimerization | 1 | 2002 | 881 | 0.010 |
Why?
|
| Colchicine | 1 | 1982 | 256 | 0.010 |
Why?
|
| Vinblastine | 1 | 1982 | 483 | 0.010 |
Why?
|
| Receptor, Angiotensin, Type 1 | 1 | 2001 | 153 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2008 | 1789 | 0.010 |
Why?
|
| omega-N-Methylarginine | 1 | 2000 | 108 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 2003 | 578 | 0.010 |
Why?
|
| Hypercholesterolemia | 1 | 2008 | 1145 | 0.010 |
Why?
|
| Fibrinolysis | 1 | 2002 | 331 | 0.010 |
Why?
|
| Comorbidity | 1 | 2015 | 10577 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2002 | 924 | 0.010 |
Why?
|
| Microspheres | 1 | 2003 | 773 | 0.010 |
Why?
|
| Iontophoresis | 1 | 1999 | 74 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2007 | 2927 | 0.010 |
Why?
|
| Morpholines | 1 | 2002 | 584 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 1649 | 0.010 |
Why?
|
| RNA Stability | 1 | 2001 | 319 | 0.010 |
Why?
|
| Chondrosarcoma | 1 | 1982 | 301 | 0.010 |
Why?
|
| Nitroprusside | 1 | 1999 | 271 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 7840 | 0.010 |
Why?
|
| Liver Diseases | 1 | 2008 | 1304 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2005 | 2677 | 0.010 |
Why?
|
| Nervous System | 1 | 2002 | 542 | 0.010 |
Why?
|
| Primary Prevention | 1 | 2006 | 1186 | 0.010 |
Why?
|
| Retinal Ganglion Cells | 1 | 2005 | 808 | 0.010 |
Why?
|
| Bucladesine | 1 | 1998 | 117 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 2002 | 931 | 0.010 |
Why?
|
| Genes, jun | 1 | 1998 | 69 | 0.010 |
Why?
|
| Proteoglycans | 1 | 1982 | 794 | 0.010 |
Why?
|
| Photic Stimulation | 1 | 2005 | 1989 | 0.010 |
Why?
|
| Genes, fos | 1 | 1998 | 176 | 0.010 |
Why?
|
| Glucose Transporter Type 1 | 1 | 1998 | 186 | 0.010 |
Why?
|
| Mitogens | 1 | 1998 | 228 | 0.010 |
Why?
|
| Insulinoma | 1 | 1998 | 121 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2004 | 1505 | 0.010 |
Why?
|
| Healthcare Disparities | 1 | 2013 | 3406 | 0.010 |
Why?
|
| Protein Multimerization | 1 | 1982 | 959 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1999 | 628 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1984 | 1440 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2005 | 2667 | 0.010 |
Why?
|
| Zinc | 1 | 1981 | 675 | 0.010 |
Why?
|
| Heart Rate | 1 | 2009 | 4203 | 0.010 |
Why?
|
| Retroelements | 1 | 1998 | 163 | 0.010 |
Why?
|
| Fibrinogen | 1 | 2000 | 894 | 0.010 |
Why?
|
| Purinergic P1 Receptor Antagonists | 1 | 1996 | 45 | 0.010 |
Why?
|
| Isoquinolines | 1 | 1998 | 350 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2000 | 1748 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1986 | 2394 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2002 | 1742 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2002 | 1674 | 0.010 |
Why?
|
| Primary Health Care | 1 | 2013 | 4735 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2001 | 1670 | 0.010 |
Why?
|
| ras Proteins | 1 | 2001 | 1054 | 0.010 |
Why?
|
| Swine | 2 | 1983 | 5986 | 0.010 |
Why?
|
| Acarbose | 1 | 1995 | 10 | 0.010 |
Why?
|
| Neurons | 1 | 2015 | 9521 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1981 | 3051 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1999 | 1695 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2005 | 2429 | 0.010 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 1999 | 553 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2005 | 2849 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2000 | 1195 | 0.010 |
Why?
|
| Fetus | 1 | 2002 | 1878 | 0.010 |
Why?
|
| Cell Survival | 1 | 2005 | 5744 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1999 | 1885 | 0.010 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 1996 | 308 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2004 | 3399 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1996 | 484 | 0.010 |
Why?
|
| alpha 1-Antitrypsin | 1 | 1995 | 168 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2002 | 2864 | 0.010 |
Why?
|
| Incidence | 1 | 2012 | 21509 | 0.010 |
Why?
|
| Polytetrafluoroethylene | 1 | 1995 | 242 | 0.010 |
Why?
|
| Vasoconstriction | 1 | 1996 | 593 | 0.010 |
Why?
|
| Infusion Pumps, Implantable | 1 | 1994 | 158 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 1999 | 1610 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1995 | 682 | 0.010 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1995 | 647 | 0.010 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 1999 | 844 | 0.010 |
Why?
|
| Rats, Inbred WF | 1 | 1992 | 139 | 0.010 |
Why?
|
| Indicators and Reagents | 2 | 1983 | 456 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 81544 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1992 | 316 | 0.010 |
Why?
|
| Retinoblastoma | 1 | 1995 | 316 | 0.010 |
Why?
|
| Aging | 1 | 2011 | 8723 | 0.010 |
Why?
|
| Homeostasis | 1 | 2003 | 3338 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2004 | 2766 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2000 | 6324 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1998 | 6101 | 0.010 |
Why?
|
| Vision Disorders | 1 | 1998 | 1087 | 0.010 |
Why?
|
| Biological Assay | 2 | 1983 | 626 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1993 | 1677 | 0.010 |
Why?
|
| Respiration | 1 | 1996 | 1653 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 1982 | 2249 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 2 | 1982 | 508 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1993 | 1527 | 0.010 |
Why?
|
| Mammalian orthoreovirus 3 | 1 | 1989 | 45 | 0.010 |
Why?
|
| Hemagglutinins, Viral | 1 | 1989 | 66 | 0.010 |
Why?
|
| Thrombosis | 1 | 2002 | 2953 | 0.000 |
Why?
|
| Age Factors | 1 | 2005 | 18382 | 0.000 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1995 | 3733 | 0.000 |
Why?
|
| Interferon-gamma | 1 | 1995 | 3159 | 0.000 |
Why?
|
| Skin | 1 | 1999 | 4482 | 0.000 |
Why?
|
| Practice Guidelines as Topic | 1 | 2003 | 7423 | 0.000 |
Why?
|
| Affinity Labels | 1 | 1984 | 107 | 0.000 |
Why?
|
| Mutation | 1 | 2009 | 30210 | 0.000 |
Why?
|
| Chromatography, Gel | 1 | 1984 | 631 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1995 | 4555 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 11035 | 0.000 |
Why?
|
| Chymotrypsin | 1 | 1982 | 136 | 0.000 |
Why?
|
| Models, Structural | 1 | 1981 | 338 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1998 | 11642 | 0.000 |
Why?
|
| Pregnancy | 1 | 2002 | 30228 | 0.000 |
Why?
|
| Pancreatic Neoplasms | 1 | 1998 | 5454 | 0.000 |
Why?
|
| Insulin Antagonists | 1 | 1980 | 17 | 0.000 |
Why?
|
| Antibody Specificity | 1 | 1982 | 1061 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1980 | 860 | 0.000 |
Why?
|
| Epitopes | 1 | 1982 | 2523 | 0.000 |
Why?
|
| Protein Conformation | 1 | 1981 | 3947 | 0.000 |
Why?
|